37 reports

  • SMOKING CESSATION AIDS
  • Smoking Cessation Aids Sales Volume by

The smoking cessation aids industry is one of key sectors of Chinese industry and has become more and more important.

  • Smoking Cessation
  • China
  • GlaxoSmithKline plc
  • Novartis AG
  • Pfizer Inc.
  • Smoking Cessation Aids Sales Volume by
  • Global Smoking Cessation Market

So one spray into each nostril gives a total amount of ## mg of nicotine, which is about the same amount of nicotine received upon smoking one cigarette.

  • Smoking Cessation
  • China
  • Demand
  • Trade
  • GlaxoSmithKline plc

Smoking Cessation and Nicotine De-Addiction Products Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2023 ##.

  • OTC
  • Smoking Cessation
  • World
  • Market Size
  • SMOKING CESSATION AIDS
  • Smoking Cessation Aids Industry Structure

The smoking cessation aids industry is one of key sectors of Chinese industry and has become more and more important.

  • Smoking Cessation
  • China
  • GlaxoSmithKline plc
  • Novartis AG
  • Pfizer Inc.

Global Market Study on Smoking Cessation and Nicotine De-addiction Products: Electronic Cigarette Product Type Segment to Register a Value CAGR of ##. ##% During the Forecast Period 2017 - 2025 ##.

  • Smoking Cessation
  • APAC
  • North America
  • World
  • Market Size
  • Global smoking cessation market 2016: $7.12 billion
  • GLOBAL SMOKING CESSATION MARKET 2016-2021 ($ BILLIONS)

Nicotine gum can be used regularly (one piece of gum every ##-## hours for the first ## weeks, followed by one piece every ##-## hours for ## weeks, and then one piece every ##-## hours for ## weeks).

  • Smoking Cessation
  • World
  • Market Size
  • GlaxoSmithKline plc
  • Novartis AG

Smoking Cessation Phase ## Clinical Trials, 2016 ##.

  • Smoking Cessation
  • France
  • Germany
  • United States
  • Market Size

Smoking Cessation Products - Market Trends & Insights ##.

  • OTC
  • Smoking Cessation
  • World
  • Demand
  • Market Size
  • GLOBAL SMOKING CESSATION PRODUCTS MARKET BY TYPE
  • PFIZER IN GLOBAL SMOKING CESSATION PRODUCTS MARKET

You can easily book an appointment with one online.

  • Smoking Cessation
  • GlaxoSmithKline plc
  • ITC Limited
  • Pfizer Inc.
  • Reynolds American Inc.

Smoking Cessation Phase ## Clinical Trials, 2016 ##.

  • Smoking Cessation
  • France
  • Germany
  • Italy
  • Market Size

Smoking Cessation Phase ## Clinical Trials, 2016 ##.

  • OTC
  • Smoking Cessation
  • Japan
  • Market Size

Smoking Cessation Phase ## Clinical Trials, 2016 ##.

  • OTC
  • Smoking Cessation
  • United States
  • Market Size

Smoking Cessation Phase ## Clinical Trials, 2016 ##.

  • OTC
  • Smoking Cessation
  • Italy
  • Market Size

Smoking Cessation Phase ## Clinical Trials, 2016 ##.

  • OTC
  • Smoking Cessation
  • Germany
  • Market Size

Smoking Cessation Phase ## Clinical Trials, 2016 ##.

  • OTC
  • Smoking Cessation
  • France
  • Market Size

Smoking Cessation Phase ## Clinical Trials, 2016 ##.

  • OTC
  • Smoking Cessation
  • United Kingdom
  • Market Size

Smoking Cessation Phase ## Clinical Trials, 2016 ##.

  • OTC
  • Smoking Cessation
  • Spain
  • Market Size
  • Smoking cessation products market in the US 2016-2021 ($ billions)
  • Segmentation of market by products

You can easily book an appointment with one online.

  • Smoking Cessation
  • United States
  • Demand
  • Forecast
  • Market Size

INTRODUCTION.............. ## ##.

  • OTC
  • Smoking Cessation
  • World
  • Demand
  • Market Size
  • JANSSEN-CILAG OY

Its core interest lies in NRT smoking cessation aids, with the Nicorette brand.

  • OTC
  • Smoking Cessation
  • Finland
  • Demand
  • Forecast
  • MCNEIL DENMARK APS
  • Passport 2

ONE OF THE REASONS BEHIND THIS WAS THAT MCNEIL DENMARK' S SHARE IN NRT SMOKING CESSATION AIDS, WHICH ACCOUNTED FOR ##% OF THE COMPANY TOTAL VALUE SALES IN 2016, HAS BEEN LOSING SHARE IN RECENT YEARS.

  • OTC
  • Smoking Cessation
  • Denmark
  • Demand
  • Market Competition
  • Challenges and Opportunities Facing Nrt Smoking Cessation Aids
  • Nicorette Nrt Smoking Cessation Aids Now Available on General Sale

All of these measures and the status change to the retail distribution of NRT smoking cessation aids should have a significant impact on NRT smoking cessation aids sales in Ireland.

  • Smoking Cessation
  • Ireland
  • Demand
  • Kelkin Ltd
  • Reckitt Benckiser Group plc
  • Smoking Cessation Products
  • Seven: Smoking Cessation Products

Chapter Seven: Smoking Cessation Products Table ##-## THE U. S.

  • Smoking Cessation
  • United States
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Pfizer Inc.

Smoking Cessation - Pipeline Insight, 2019 ##.

  • Pharmaceutical
  • Smoking Cessation
  • Therapy

Smoking Cessation Pipeline Highlights – 2017 ##.

  • OTC
  • Smoking Cessation
  • United States
  • Product Initiative
  • Jan 12, 2012: Inverseon Focuses On Smoking Cessation As Initial Indication For INV102
  • Nov 11, 2013: Change to FDA reviewing division for smoking cessation clinical trial

Patients who fail to respond to bupropion during this lead-in period will be randomly assigned in a ##:## ratio to receive bupropion or AXS-## in a double-blind fashion for ## weeks.

  • Pharmaceutical
  • Smoking Cessation
  • United States
  • Product Initiative
  • Invion Limited
  • SMALL MOLECULES TO ANTAGONIZE CHRNB2 AND CHRNA4 FOR SMOKING CESSATION - DRUG PROFILE
  • CYTISINE - DRUG PROFILE

The molecules developed by companies in Phase II, Phase I, Preclinical and Discovery stages are ##, ##, ## and ## respectively.

  • Smoking Cessation
  • Therapy
  • World
  • Product Initiative
  • Suven Life Sciences Ltd
  • SMALL MOLECULES TO ANTAGONIZE CHRNB2 AND CHRNA4 FOR SMOKING CESSATION - DRUG PROFILE
  • CYTISINE - DRUG PROFILE

The molecules developed by companies in Phase II, Phase I, Preclinical and Discovery stages are ##, ##, ## and ## respectively.

  • Smoking Cessation
  • Therapy
  • World
  • Product Initiative
  • Suven Life Sciences Ltd
  • Nov 11, 2013: Change to FDA reviewing division for smoking cessation clinical trial
  • Feb 02, 2015: Invion completes enrolment in its phase II trial of oral INV102 (nadolol) in smoking cessation

The molecules developed by Companies in Phase III, Phase II, Phase I, Preclinical, Discovery and Unknown stages are ##, ##, ##, ##, ## and ## respectively.

  • Pharmaceutical
  • Smoking Cessation
  • Therapy
  • United States
  • Product Initiative